strong ep beat gener bullish forward
commentari particularli disinfecting/clean product
portfolio drive ep increas ep
forecast high visibl
solid ep gener bullish tone outlook stock trade
vs declin combin solid ep beat even
high bar head quarter bullish commentari around
forward outlook beyond notabl around growth potenti
disinfect product portfolio top-line org sale report revenu
consensu margin upsid gm bp ahead
consensu strong top-line leverag mix shift toward higher margin
clean segment drove sizeabl ep beat also rais
guidanc wide rang impli org sale hsd high teen
impli ep bracket consensu sharpli
increas consum demand clean product covid situat
quantifi expand product disinfect product
intern third-parti capac although short-term covid cost
weigh gm upsid rais ep
rais pt valu price-to-earnings high
end us hpc peer rang
detail call disinfect product sale mix
clean segment see sustain growth consum
demand manag view abl increas product
product quarter plan invest
addit capac segment rais capital-expenditure outlook
sale vs histor level sever key categori trash
bag charcoal salad dress water filter among other benefit
near-term at-hom shelter charcoal success recent
launch kingsford pellet pre-covid track deliv
target distribut gain drive top-line re-acceler lsd/msd
rang within clean segment sale profession
channel primarili disinfect product healthcar facil saw strong dd
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
growth continu priorit suppli channel
sale growth untrack channel nearli point higher
track channel e-commerce/club grow doubl rate track
channel continu invest trade promot net price
yoy well face major
supply/product disrupt facil although note third
parti produc face labor shortag constraint dietari supplement
categori gross margin look pois face increment headwind
covid relat cost includ compens suppli chain area
manag guid roughli bp gm expans
impli y/i contract follow sizeabl bp y/i expans
outlook advertis spend remain stabl sale
dollar amount increas higher sale highlight
increment ad spend back half temporarili
suspend share repurchas program
number report ep well consensu
mse strong volum growth drove point
top-line upsid well point oper profit upsid combin
oper leverag cost save organ sale growth came
expect driven sharp organ sale clean
segment mse doubl digit shipment across busi unit
elev demand disinfect wipe covid environ
household mse lifestyl mse
mse comment saw double-digit volum growth
everi geograph region off-set point fx headwind segment
point level report revenu beat consensu gross
profit oper profit beat consensu gm upsid
bp vs consensu higher volum growth flow profit line
partial off-set higher trade promot ep beat consensu similar
higher expens off-set lower expect tax rate
sale growth segment clean segment organ sale yoy
vs doubl digit shipment growth busi unit
highlight signific contribut consum profession
product due elev demand brand disinfect product
includ wipe bleach household penetr brand rose
quarter household segment organ sale grew yoy vs
strength cat litter grill partial off-set higher promot
spend net price yoy segment lifestyl segment
organ sale grew yoy vs growth four
segment busi unit except dietari supplement face
covid-rel suppli disrupt quarter whole estim
domest organ sale grew yoy vs meanwhil
organ sale growth acceler yoy vs
driven combin volum price/mix implement
covid report double-digit growth everi intern geograph
rais organ sale ep guidanc rais ep guidanc
prior vs consensu mse
rais organ sale growth guidanc prior flat
driven increas demand impact report
sale guid prior -lsd declin includ
impact fx indic base earli trend quarter
pre-covid sale track line prior guidanc return organ
sale growth back half fiscal year reflect increas product
demand driven custom plan back-half innov higher consum
invest lead expand distribut gross margin expect
roughli bp yoy reflect benefit oper
leverag driven sale momentum cost save initi partial off-set
invest employe safeti higher wage benefit well
higher transport wareh cost line item guidanc includ
 expect sale vs slightli sale
prior ii sell administr cost sale sale vs
sale prior due higher incent compens iii tax
rate vs prior worth cent reflect increas excess tax
benefit incent compens
pt deriv ep slightli averag
rel hpc peer
rel hpc peer near-
term top-line like robustli
support covid-rel demand boost
clean product project
organ growth vs
driven busi relat
clean believ longer term
remain overindex low-growth
product categori high exposur
us
ev/ebitda
price-to-earnings high comparison pg
growth strateg potenti rel
view descript risk reward theme
thomson reuter morgan stanley research morgan stanley institut equiti divis probabl
bull base bear case scenario play estim impli volatil data option market
may gure approxim risk-neutr probabl stock reach beyond scenario price
either three-month one-year time view explan option probabl methodolog
top-line margin upsid bp
better expect volum near-term
last bp margin upsid
declin commod cost
upsid cost-cut drive multipl
expans bull case ep
lower long-term ep growth peer
lower long-term ep growth peer
top line growth bp averag
margin expans near-term top-lin
acceler driven above-trendcovid-
relat demand growth clean
segment expect valuat
ep averag
hpc environ drive bp us price
downsid coupl bp volum
downsid near-term covid-rel
demand dissip post
margin reinvest busi
multipl compress bear case
gross margin chang bp
advertis cost sale chang
bp
oper margin chang bp
impact boost sale wipe
improv price gap privat label key
shelf space recaptur innov
china india
view explan region hierarchi
research highest favor quintil
million increment save
bp reinvest
top-line margin upsid improv price
better expect volum declin
cost-cut
price take hold worsen volum
higher expect commod inat
heighten competit privat label
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
million except ep
product sold
net sale
chang bp
net sale
chang bp
sell administr
net sale
chang bp
total sale
chang bp
total sale
chang bp
net sale
chang bp
net sale
net earn cont op
net sale
ep continu op
asset held sale
net properti plant equip
note loan payabl
current matur lt debt
accru liabil
common stock apic
accumul comprehens loss
total liabil stockhold equiti
depreci amort
chang a/l
accru liabil
net cash discontinu oper
net cash oper
net cash invest
purchas treasuri stock
net cash financ
effect fx chang cash
net chang cash
begin cash equival
end cash equival
valuat methodolog risk
pt deriv price-to-earnings multipl given recent acceler growth
improv fundament org sale growth given temporari
benefit net em weak long-term greater
reinvest stronger innov pipelin
risk upsid
stronger price greater market share payback ad spend int categori rebound
consolid potenti increas
risk downsid
weaker price weaker em growth impact market share loss local
player categori growth slowdown stronger usd higher commod cost
pt deriv multipl ep premium mega-cap
peer consid pg favor long-term top-line growth margin expans
risk upsid
favor price environ cost-cut upsid higher market share gain key
categori relat pantri load tailwind moder currenc
risk downsid
macro pressur unfavor price environ market share loss
